Question 1

What are the potential benefits of participating in this trial for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of the Efficacy and Safety of THRV-1268 in Participants With Long QT Syndrome Type 2 (LQTS2) and Type 3 (LQTS3) clinical trial (NCT07277582). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I be aware of while taking THRV-1268?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of the Efficacy and Safety of THRV-1268 in Participants With Long QT Syndrome Type 2 (LQTS2) and Type 3 (LQTS3) clinical trial (NCT07277582). Contact the study team or your healthcare provider for specific answers.

Question 3

How often will I need to come in for visits and tests during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of the Efficacy and Safety of THRV-1268 in Participants With Long QT Syndrome Type 2 (LQTS2) and Type 3 (LQTS3) clinical trial (NCT07277582). Contact the study team or your healthcare provider for specific answers.

Question 4

What will happen if I experience side effects or complications during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of the Efficacy and Safety of THRV-1268 in Participants With Long QT Syndrome Type 2 (LQTS2) and Type 3 (LQTS3) clinical trial (NCT07277582). Contact the study team or your healthcare provider for specific answers.

Question 5

How does THRV-1268 compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of the Efficacy and Safety of THRV-1268 in Participants With Long QT Syndrome Type 2 (LQTS2) and Type 3 (LQTS3) clinical trial (NCT07277582). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there any risk of my condition worsening while participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of the Efficacy and Safety of THRV-1268 in Participants With Long QT Syndrome Type 2 (LQTS2) and Type 3 (LQTS3) clinical trial (NCT07277582). Contact the study team or your healthcare provider for specific answers.

What this study is about